Remarkable progress has been made during the past decade in our understanding of
mechanisms of cell death in neurodegenerative disorders such as Parkinson's disease (PD) …

Minocycline, a semisynthetic tetracycline-derived antibiotic, has been shown to exert anti-
apoptotic, anti-inflammatory, and antioxidant effects. Furthermore, there is rapidly growing …

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by
cardinal features of tremor, bradykinesia, rigidity and postural instability. In addition to the …

Minocycline, an antibiotic of the tetracycline family, has been shown to display
neurorestorative or neuroprotective properties in various models of neurodegenerative …

Tetracyclines are a class of antibiotics which could play a therapeutic role in several
neurological disorders. Minocycline, extensively studied in animal models, decreased the …

Tetracyclines are a class of antibiotics which could act as neuroprotective molecules in
several neurological disorders, such as Huntington disease, Parkinson disease, stroke and …

The prevalence of Parkinson's disease, which affects millions of people worldwide, is
increasing due to the aging population. In addition to the classic motor symptoms caused by …

Minocycline has been shown to exert anti‐inflammatory effects underlying its putative
neuroprotective properties in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP) …

Minocycline is a member of the tetracycline class of molecules with broad-spectrum
antibiotic activity. The unique properties of minocycline result in increased tissue distribution …

Several studies have shown that minocycline, a semisynthetic, second-generation
tetracycline derivative, is neuroprotective in animal models of central nervous system trauma …